market folly

Yesterday, we saw that Goldman Sachs made a few changes to their Conviction Lists. Notably, they added Wyeth (WYE) to the buy list, giving the stock a breakup value of $50 a share. They currently have a price target of $46 on the shares. Additionally, Autoliv (ALV) was removed from the conviction buy list. But, they still retain a normal 'buy' rating on the name. You can check out the rest of the recent updates to the GS conviction buy and sells lists here and here.

Taken from Google Finance, Wyeth (WYE) is "engaged in the discovery, development, manufacture, distribution and sale of a line of products in three primary businesses: Wyeth Pharmaceuticals (Pharmaceuticals), Wyeth Consumer Healthcare (Consumer Healthcare), and Fort Dodge Animal Health (Animal Health)."

Autoliv (ALV) is "a supplier of automotive safety systems with a range of product offerings, including modules and components for passenger and driver-side airbags, side-impact airbag protection systems, seatbelts, steering wheels, safety electronics, whiplash protection systems and child seats, as well as night vision systems and other active safety systems."